Dietary antioxidant capacity of the patients with cardiovascular disease in a cross-sectional study

Małgorzata E Zujko1, Anna M Witkowska2, Anna Waśkiewicz3

  • 1Department of Food Commodities Science and Technology, Medical University, Szpitalna 37, Bialystok, 15-295, Poland. malgorzata.zujko@umb.edu.pl.

Nutrition Journal
|April 17, 2015
PubMed

Insights

Cardiovascular disease patients in Poland increase their intake of antioxidants, polyphenols, and flavonoids. Dietary patterns differ between men and women with cardiovascular disease (CVD).

Area of Science:

  • Nutrition Science
  • Cardiovascular Health
  • Dietary Analysis

Background:

  • Cardiovascular disease (CVD) is a significant health concern.
  • Dietary factors play a crucial role in CVD management and prevention.
  • Antioxidants, polyphenols, and flavonoids are key dietary compounds with potential health benefits.

Purpose of the Study:

  • To identify the sources and dietary patterns of antioxidant, polyphenol, and flavonoid intake.
  • To compare these intakes between men and women with CVD and healthy controls (HC).
  • To understand dietary modifications in Polish individuals with CVD.

Main Methods:

  • Utilized data from the Polish National Multicenter Health Survey (WOBASZ).
  • Employed a 1-day 24-hour dietary recall method for food intake assessment.
  • Calculated dietary total antioxidant capacity (DTAC), total polyphenol content (DTPC), and total flavonoid content (DTFC) using a specialized database.

Main Results:

  • Women with CVD showed significantly higher DTAC, DTPC, and DTFC compared to HC women.
  • Antioxidant sources included tea, coffee, apples, nuts, seeds, and strawberries.
  • Polyphenol sources included tea, coffee, cabbage, potatoes, apples, and white bread.
  • Flavonoid sources across all groups were primarily tea, apples, cabbage, and coffee.
  • No significant differences in DTAC, DTPC, or DTFC were observed between men with CVD and HC men.

Conclusions:

  • Polish individuals with CVD adopt beneficial dietary changes, increasing intake of antioxidants, polyphenols, and flavonoids.
  • Distinct dietary sources and patterns for these compounds exist between male and female CVD patients.
  • Dietary interventions should consider sex-specific patterns for CVD management.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
603
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
225
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
867
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.1K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K